{
    "id": "161",
    "title": "Multiple Myeloma Response Criteria",
    "desc": "The Multiple Myeloma Response Criteria (IMWG) predicts disease response in multiple myeloma.",
    "data": {
        "orgreference": [
            {
                "href": "https://www.nature.com/articles/leu2008291/",
                "text": "Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009;23(1):3-9."
            }
        ],
        "other_refer": [],
        "evidence": "<p dir=\"ltr\">Selection of the appropriate criteria:</p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"302\" /><col width=\"146\" /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Criteria</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Response category</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Negative immunofixation of serum and urine AND disappearance of any soft tissue plasmacytomas AND &lt;5% plasma cells in bone marrow</p>\n</td>\n<td>\n<p dir=\"ltr\">Complete response (CR)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">CR as defined above plus normal FLC ratio (0.26-1.65) AND absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence</p>\n</td>\n<td>\n<p dir=\"ltr\">Stringent complete response (sCR)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Serum and urine M component detectable by immunofixation but not on electrophoresis OR &ge;90% reduction in serum M component plus urine M component &lt;100&thinsp;mg per 24&thinsp;hrs</p>\n</td>\n<td>\n<p dir=\"ltr\">Very good partial response (VGPR)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&ge;50% reduction of serum M protein and reduction in 24 hr urinary M protein by &ge;90% or to &lt;200&thinsp;mg per 24&thinsp;hrs</p>\n<p dir=\"ltr\">If serum and urine M protein are unmeasurable, &ge;50% decrease in the difference between involved and uninvolved FLC levels is required in place of the M protein criteria</p>\n<p dir=\"ltr\">If serum and urine M protein are unmeasurable, and serum free light assay is also unmeasurable, &ge;50% reduction in bone marrow plasma cells is required in place of M protein, provided baseline percentage was &ge;30%</p>\n<p dir=\"ltr\">In addition to the above criteria, if present at baseline, &ge;50% reduction in the size of soft tissue plasmacytomas is also required</p>\n</td>\n<td>\n<p dir=\"ltr\">Partial response (PR)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Not meeting criteria for CR, VGPR, PR, or progressive disease</p>\n</td>\n<td>\n<p dir=\"ltr\">Stable disease (SD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">25% increase from lowest response value in &ge;1 of the following:</p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Serum M component (absolute increase must be &ge;0.5&thinsp;g/100&thinsp;mL)</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Urine M component (absolute increase must be &ge;200&thinsp;mg per 24&thinsp;hrs)</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Only in patients without measurable serum and urine M protein levels: difference between involved and uninvolved FLC levels (absolute increase must be &gt;100&thinsp;mg/L)</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Bone marrow plasma cell percentage (absolute % must be &ge;10%)</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Definite development of new bone lesions or soft tissue plasmacytomas or definite increase in the size of existing bone lesions or soft tissue plasmacytomas</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Development of hypercalcemia (<calculator id=\"31\">corrected serum calcium</calculator>&nbsp;must be &gt;11.5&thinsp;mg/dL) that can be attributed solely to the plasma cell proliferative disorder</p>\n</li>\n</ul>\n</td>\n<td>\n<p dir=\"ltr\">Progressive disease (PD)</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>",
        "facts": "",
        "estimation": [],
        "primary_complains": [
            "Extremity Pain",
            "Cancer"
        ],
        "disease_treated": [
            "Multiple Myeloma"
        ],
        "logic": "var calc_output = [];\n\nvar one = parseFloat(one);\nvar two = parseFloat(two);\nvar three = parseFloat(three) || 0;\nvar four = parseFloat(four) || 0;\nvar five = parseFloat(five) || 0;\nvar six = parseFloat(six) || 0;\nvar seven = parseFloat(seven) || 0;\nvar eight = parseFloat(eight) || 0;\nvar nine = parseFloat(nine) || 0;\nvar ten = parseFloat(ten) || 0;\n\nvar pd = five + six + seven + eight + nine + ten;\nvar diag, msg;\n\nif (two == 1) {\n  diag = 'sCR';\n  msg = 'Stringent complete response by IMWG criteria';\n} else if (one == 1) {\n  diag = 'CR';\n  msg = 'Complete response by IMWG criteria';\n} else if (three == 1) {\n  diag = 'VGPR';\n  msg = 'Very good partial response by IMWG criteria';\n} else if (four == 1) {\n  diag = 'PR';\n  msg = 'Partial response by IMWG criteria';\n} else if (pd >= 1) {\n  diag = 'PD';\n  msg = 'Progressive disease by IMWG criteria';\n} else {\n  diag = 'SD';\n  msg = 'Stable disease by IMWG criteria';\n} \n\n//results\ncalc_output.push({\n    name: 'mini',\n    value: diag,\n    value_text: '',\n    message: msg\n});\ncalc_output.push({\n    name: 'diag',\n    value: diag,\n    value_text: '',\n    message: msg\n});\n",
        "inputs": [
            {
                "conditionality": "",
                "default": 0,
                "label_en": "Less than 5% of plasma cells in the bone marrow, absence of any soft tissue plasmacytomas, and negative immunofixation of the serum and urine. ",
                "name": "one",
                "optional": false,
                "options": [
                    {
                        "label": "No",
                        "value": 0
                    },
                    {
                        "label": "Yes",
                        "value": 1
                    }
                ],
                "show_points": false,
                "tips_en": "",
                "type": "toggle"
            },
            {
                "conditionality": "",
                "default": 0,
                "label_en": "the aforementioned requirements in addition to a normal FLC ratio (0.26–1.65) AND the lack of clonal cells in the bone marrow as determined by immunohistochemistry or immunofluorescence. ",
                "name": "two",
                "optional": false,
                "options": [
                    {
                        "label": "No",
                        "value": 0
                    },
                    {
                        "label": "Yes",
                        "value": 1
                    }
                ],
                "show_points": false,
                "tips_en": "",
                "type": "toggle"
            },
            {
                "conditionality": "one != 1",
                "default": 0,
                "label_en": "either hematocrit <36 percent or hemoglobin <12 g/dL. ",
                "name": "three",
                "optional": false,
                "options": [
                    {
                        "label": "No",
                        "value": 0
                    },
                    {
                        "label": "Yes",
                        "value": 1
                    }
                ],
                "show_points": false,
                "tips_en": "",
                "type": "toggle"
            },
            {
                "conditionality": "one != 1",
                "default": 0,
                "label_en": ">74 years of age. ",
                "name": "four",
                "optional": false,
                "options": [
                    {
                        "label": "No",
                        "value": 0
                    },
                    {
                        "label": "Yes",
                        "value": 1
                    }
                ],
                "show_points": false,
                "tips_en": "See <a href = \"#evidence\">Evidence</a> for criteria if serum and urine M protein are unmeasurable",
                "type": "toggle"
            },
            {
                "subheading": "25% increase from lowest response value in the following (select any that apply):",
                "subheading_instructions": "",
                "type": "subheading"
            },
            {
                "conditionality": "one != 1",
                "default": 0,
                "label_en": "Serum M component. ",
                "name": "five",
                "optional": false,
                "options": [
                    {
                        "label": "No",
                        "value": 0
                    },
                    {
                        "label": "Yes",
                        "value": 1
                    }
                ],
                "show_points": false,
                "tips_en": "Absolute increase must be ≥0.5 g/100 mL",
                "type": "toggle"
            },
            {
                "conditionality": "one != 1",
                "default": 0,
                "label_en": "componenti di urina M. ",
                "name": "six",
                "optional": false,
                "options": [
                    {
                        "label": "No",
                        "value": 0
                    },
                    {
                        "label": "Yes",
                        "value": 1
                    }
                ],
                "show_points": false,
                "tips_en": "Absolute increase must be ≥200 mg per 24 hrs",
                "type": "toggle"
            },
            {
                "conditionality": "one != 1",
                "default": 0,
                "label_en": "Only in patients without measurable serum and urine M protein levels: difference between involved and uninvolved FLC levels",
                "name": "seven",
                "optional": false,
                "options": [
                    {
                        "label": "No",
                        "value": 0
                    },
                    {
                        "label": "Yes",
                        "value": 1
                    }
                ],
                "show_points": false,
                "tips_en": "Absolute increase must be >100 mg/L",
                "type": "toggle"
            },
            {
                "conditionality": "one != 1",
                "default": 0,
                "label_en": "Il numero di plasmacelle nella marrow. ",
                "name": "eight",
                "optional": false,
                "options": [
                    {
                        "label": "No",
                        "value": 0
                    },
                    {
                        "label": "Yes",
                        "value": 1
                    }
                ],
                "show_points": false,
                "tips_en": "Absolute % must be ≥10%",
                "type": "toggle"
            },
            {
                "conditionality": "one != 1",
                "default": 0,
                "label_en": "a clear increase in the size of pre-existing soft tissue plasmacytomas or bone lesions, or the definitive development of new ones in these tissues. ",
                "name": "nine",
                "optional": false,
                "options": [
                    {
                        "label": "No",
                        "value": 0
                    },
                    {
                        "label": "Yes",
                        "value": 1
                    }
                ],
                "show_points": false,
                "tips_en": "",
                "type": "toggle"
            },
            {
                "conditionality": "one != 1",
                "default": 0,
                "label_en": "Development of hypercalcemia that can be attributed solely to the plasma cell proliferative disorder",
                "name": "ten",
                "optional": false,
                "options": [
                    {
                        "label": "No",
                        "value": 0
                    },
                    {
                        "label": "Yes",
                        "value": 1
                    }
                ],
                "show_points": false,
                "tips_en": "<calculator id = \"31\">Corrected serum calcium</calculator> must be >11.5 mg/dL",
                "type": "toggle"
            }
        ],
        "can_search": [
            "Mm",
            "Multiple Myeloma Response Criteria (IMWG)",
            "multiple myeloma",
            "disease response",
            "multiple myeloma response assessment",
            "myeloma",
            "imwg"
        ],
        "specialty": [
            "Radiation Oncology",
            "Internal Medicine",
            "Hospitalist Medicine",
            "Hematology and Oncology"
        ]
    }
}